Garland Jonathan Todd 4
4 · Cytek Biosciences, Inc. · Filed Apr 27, 2022
Insider Transaction Report
Form 4
Garland Jonathan Todd
Chief Commercial Officer
Transactions
- Award
Restricted Stock Units
2022-04-25+31,217→ 31,217 total→ Common Stock (31,217 underlying) - Award
Stock Option (right to buy)
2022-04-25+46,971→ 46,971 totalExercise: $9.61Exp: 2032-04-25→ Common Stock (46,971 underlying)
Footnotes (3)
- [F1]The option will vest as follows: 25% of the total shares underlying the option shall vest on April 25, 2023 and 1/48 of the total shares underlying the option shall vest each month thereafter.
- [F2]Each Restricted Stock Unit (the "RSU Award") represents a contingent right to receive one share of the Issuer's common stock.
- [F3]The shares subject to the RSU Award shall vest quarterly over four years, with 12/48th of the total shares underlying the RSU Award vesting on May 18, 2023 and 3/48th of the total shares underlying the RSU Award vesting each subsequent quarter thereafter on August 18, November 18, February 18 and May 18.